Articles in 2009

Filter By:

  • VEPTP and the ANG-TIE2 pathway regulate blood vessel size in tumour angiogenesis.

    • Meera Swami
    Research Highlight
  • Many factors, including genetic and epigenetic alterations, antigenic drive and the microenvironment, are crucial in the initiation and progression of chronic lymphocytic leukaemia (CLL). How will our growing understanding of CLL biology lead to the translation of therapeutic targets and prognostic markers into clinical practice?

    • Thorsten Zenz
    • Daniel Mertens
    • Stephan Stilgenbauer
    Review Article
  • Evidence indicates that the disruption of the circadian clock might be directly linked to cancer. As described here, alterations in clock function could lead to aberrant cellular proliferation, DNA damage responses and altered metabolism.

    • Saurabh Sahar
    • Paolo Sassone-Corsi
    Review Article
  • The mucin family of transmembrane and secreted glycoproteins form a barrier that protects the epithelium. Mucins affect epithelial polarity, inflammation, and cell growth and survival signalling; all of these functions could have roles in tumour formation and progression. This Review highlights the functions of mucins in cancer and discusses how these proteins are being targeted therapeutically.

    • Donald W. Kufe
    Review Article
  • The p53 pathway is deregulated in almost all tumours making it a prime target for new cancer drug development. This Review discusses the new approaches to drug discovery that are currently being used to target the p53 pathway and the progress made with the drugs that have been developed so far.

    • Christopher J. Brown
    • Sonia Lain
    • David P. Lane
    Review Article